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Gorham’s disease, also known as idiopathic massive osteolysis, is a rare pathological condi-
tion  characterized by vascular proliferation that results in destruction and reabsorption of
the bone matrix, of unknown etiology. It was ﬁrst described by Jackson in 1838, but it was
Gorham and Stout, in 1955, who deﬁned this disease as a speciﬁc entity. It has variable clin-
ical  presentation and generally has progressive behavior. Controversy continues regarding
the  treatment and there is no standard treatment. This pathological condition generally
presents a favorable prognosis. Here, a case of Gorham’s disease with involvement of the
left  hip is presented, in a male patient without relevant antecedents.
©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved.
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A doenc¸a de Gorham, também conhecida por osteólise macic¸a idiopática, é uma patologia
rara,  caraterizada por uma proliferac¸ão vascular que resulta na destruic¸ão e reabsorc¸ão da
matriz óssea, de etiologia desconhecida. Foi descrita pela primeira vez em 1838 por Jackson,
mas foram Gorham e Stout, em 1955, que deﬁniram a doenc¸a como uma entidade especíﬁca.
Com uma apresentac¸ão clinica variável, geralmente tem um comportamento progressivo. O
tratamento permanece controverso, não há um tratamento padrão. Essa patologia apresenta
geralmente um prognóstico favorável. É apresentado um caso de doenc¸a de Gorham comenvolvimento do quadril esquerdo, num doente do sexo masculino, sem antecedentes de
relevo.
©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier Editora Work developed at the São João Hospital Center, Porto, Portugal.
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Introduction
Gorham’s disease consists of progressive idiopathic osteolysis
of a bone or bones adjacent and surrounding a focus, without
respecting joint borders.
It can affect any part of the skeleton. The sites most
affected are the cranium, shoulder and pelvis.1
The clinical presentation depends on the site involved
and many  months or years may pass by before it is diag-
nosed. In some cases, the disease is manifested acutely, with
incapacitating pain. The ﬁrst manifestations are commonly
spontaneous fractures. In other patients, Gorham’s disease
presents an insidious course, with progressive muscle weak-
ness.
This disease is of progressive nature in most of the patients
and may, in certain cases, be self-limiting. The natural course
of this pathological condition is generally benign. However,
it has complications comprising pericardial and pleural effu-
sions and these are potentially fatal if the mediastinum is
reached.
Radiological examinations, especially X-rays, computed
tomography (CT) and magnetic resonance imaging (MRI), in
association with bone biopsies, are essential for making the
differential diagnosis of this rare pathological condition.
The medical treatment of Gorham’s disease includes use
of radiotherapy, antiosteoclastic drugs (bisphosphonates) and
interferon -2b. The surgical options include resection of
the lesion and ﬁlling with autologous or heterologous graft
material or reconstruction of the joint through arthroplastic
resources.
Case  report
The patient was a 48-year-old white man  with a history of use
of intravenous drugs. He was seen at an external orthopedic
consultation with a complaint of pain in his left thigh that had
started 5 years earlier, with progressive loss of range of motion
and the capacity to walk, and increasing need for external sup-
port in order to walk. He did not have any previous history of
trauma.
At the objective examination, he presented pain upon pal-
pation of the left trochanteric region and also during passive
internal and external rotation. It was observed that during
active movements, his ﬂexion of the left hip was limited to
30◦, internal rotation to 10–15◦ and external rotation to 15–20◦.
He presented a Harris Hip Score of 36.65.
He underwent X-ray examination with the pelvis bearing
weight (Fig. 1), from which apparent bone necrosis of the left-
side femoral head and neck was observed. A CT scan on the left
hip (Fig. 2A and B) showed that complete bone reabsorption
of the left-side femoral head and neck had occurred. MRI on
the left hip (Fig. 3) also showed complete bone reabsorption
of the proximal femur, along with the presence of a vascular
“mass” in the joint space and invasion of the fossa and the
upper wall of the left acetabulum and wing of the ipsilateral
ilium. Bone scintigraphy was also performed and this revealed
destruction of the left coxofemoral joint, with late ﬁxation of
the radiopharmaceutical.Fig. 1 – X-ray of the pelvis, with weight bearing (AP view).
A biopsy was performed, directed by means of CT on the
left hip. The anatomopathological result was compatible with
Gorham’s disease and revealed the presence of dispersed
small-caliber vessels.
The patient is currently being monitored as an orthope-
dics outpatient and total arthroplasty of the left hip has been
proposed.
Discussion
Gorham’s disease, also known as Gorham–Stout syndrome, is
a rare idiopathic disease that is characterized by extensive loss
of bone matrix, which is replaced by ﬁbrotic tissue and prolife-
rative vascular and lymphatic canals. Approximately 200 cases
have been reported in the literature.2 It was ﬁrst described by
Jackson in 1838,3,4 in a case of an adult male in whom com-
plete humeral bone reabsorption was observed over an 11-year
period. In 1955, Gorham and Stout5 deﬁned this pathological
condition as a speciﬁc entity through publishing a review of
24 cases of the disease. They reported that “Gorham’s disease
is generally associated with angiomatosis of blood and lymph
vessels.
Most of the cases occur in children or in adults under
the age of 40 years. Approximately 60% of the cases occur
among male patients and there is no apparent genetic
predisposition.6 The shoulder7,8 and the pelvis9 are the loca-
tions most affected by this syndrome, although it may affect
any bone.10 When it affects the ribs, scapula or thoracic spine,
it may lead to the appearance of chylothorax, due to direct
invasion of lymphangiectasia into pleural cavity or via the
thoracic duct.11 In these cases, surgical drainage needs to
be performed. If this is not done, there are high morbidity
and mortality rates.11 Nonetheless, this syndrome generally
presents benign evolution.
Gorham’s disease is of progressive nature, but in some
cases it presents as a self-limiting pathological condition. Its
etiology and pathophysiology remain unknown. The patholog-
ical process is characterized by replacement of normal bone
by non-neoplastic vascular tissue of aggressive behavior,10,12
similar to a hemangioma or lymphangioma. In the early
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aFig. 2 – (A) CT scan of the pelvis (axial slic
tage of the lesion, the bone is reabsorbed and replaced by
ypervascular and/or angiomatous ﬁbrous connective tissue.
istologically, thin-walled vessels are seen to be present, and
hese may be capillary, sinusoidal or cavernous. At later stages,
rogressive bone destruction takes place, with the appearance
f ﬁbrotic tissue and massive osteolysis.13
The exact nature of the pathological process is unknown.
orham and Stout5 stated that hyperemia, local alterations
f pH and mechanical forces were responsible for the bone
bsorption and rules out any role for osteoclasts. Devlin et al.13
uggested that the osteolysis that is present in Gorham’s dis-
ase was due to increased activity by osteoclasts, mediated by
ncreased levels of interleukin-6 (IL-6). Moller et al.14 published
ix cases of Gorham’s disease, in which the histopathological
esults showed that there was an increased number of osteo-
lasts. Hirayama et al.15 suggested that the increase in the
umber of osteoclasts was due to greater sensitivity of the
recursors for humoral factors, which promotes formation of
steoclasts and bone reabsorption.
The clinical manifestations are variable and depend on the
ite affected. Some patients present a sudden start to pain
nd edema in the extremity affected, while others present
n insidious start to the pain, with limitation of movements
nd progressive loss of muscle strength. Despite the severe
one deformities, serious complications are rare. Paraplegia
16ay occur when vertebrae are involved. When the chest
nd mediastinum are involved, pleural effusion may develop,
Fig. 3 – MRI  of the pelvis (coronal slice).d (B) CT scan of the pelvis (coronal slice).
with consequent respiratory failure, which may have a fatal
outcome.17
The routine laboratory analyses are not useful for diag-
nosing Gorham’s disease. It is possible that only the serum
alkaline phosphatase levels will be elevated. However, rou-
tine radiological examinations such as X-rays, CT and MRI
are useful for the diagnosis. The most dramatic appearance
of massive osteolysis is seen on X-ray images. Resnick18
described the radiological ﬁndings from Gorham’s disease. In
the initial stage of the lesion, radiolucent foci appear in the
subcortical and intramedullary region, similar to osteoporosis.
Progressive dissolution, fragmentation and disappearance of
the bone portion affected are seen. The remainder of the bone
tissue forms shards and is accompanied by soft-tissue atro-
phy. The disease may extend to contiguous bones and does
not respect the joint surface as a barrier. Scintigraphy shows
increased levels of vascularization in the early stages and an
area of low uptake corresponding to the location of absence of
bone tissue at later stages.19
The diagnosis of Gorham’s disease can only be established
after other, more  common causes of osteolysis have been ruled
out, such as infection, cancer (primary or metastatic) and
endocrine and inﬂammatory diseases. Biopsies (open, echo-
guided or CT-guided) contribute toward this and establish the
deﬁnitive diagnosis.
Because of the rarity of this pathological condition, there
is no standard treatment for it. The medical treatment
includes radiotherapy,20 bisphosphonates21 and interferon
-2b.22 Radiotherapy at moderate doses (40–45 Gy in two  frac-
tions) presents good clinical results, with a low complication
rate.21 Surgical treatment, which is perhaps the main method,
includes resection of the lesion and bone reconstruction using
a bone graft, or arthroplasty. Chylothorax is the most seri-
ous complication, and this occurs when Gorham’s disease
affects the chest. This complication is potentially life threat-
ening. The surgical procedures reserved for these situations
include pleurectomy, pleurodesis and deviation to the thoracic
duct.23,24 In these cases, radiotherapy is reserved for patients
who cannot tolerate invasive procedures.Conclusion
Gorham’s disease is a rare and peculiar musculoskeletal
pathological condition in which the bone affected virtually
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disintegrates and is replaced by vascular ﬁbrous connective
tissue. Its etiology is speculative. The clinical presentation is
very variable and the natural history of the disease has an
unpredictable prognosis. No effective therapy has been estab-
lished. Most of the patients are treated with radiotherapy and
surgical procedures.
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